REGN Regeneron Pharmaceuticals

$610.04 +0.38%

Healthcare · Pharmaceutical Preparations

Regeneron Pharmaceuticals (REGN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $63.4 billion. Shares last traded at $610.04, 25.6% below their 52-week high. Over the past year the stock is up 15.5%. REGN trades at a price-to-earnings ratio of 14.08, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 31.4%, above the peer median of -0.1%. Revenue grew 1.0% year over year. The shares yield 0.6% in dividends.

Market Cap

$63.4B

Shares Out

104.0M

EPS (TTM)

$67.65

P/E Ratio

9.02

P/S Ratio

4.42

P/B Ratio

2.02

Dividend / Share

$3.58

Dividend Yield

0.59%

52-Week High

$820.37

52-Week Low

$503.33

Volume

85,180

Avg Vol (3m)

61,866.778

Performance

-0.95%

-12.62%

-19.64%

-17.71%

YTD

-21.44%

+15.48%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

38.20

SMA (50)

$686.16

SMA (200)

$696.71

Price vs SMA50

-11.09%

Price vs SMA200

-12.44%

ATR (14)

$17.80

Financials

Revenue

$14.3B

Net Income

$4.5B

Gross Margin

—

Operating Margin

24.9%

Net Margin

31.4%

Return on Equity

14.3%

Return on Assets

11.0%

Current Ratio

3.57

Debt / Equity

0.06

Revenue Growth (YoY)

+1.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$6.75	2026-04-29
FY 2025	$41.48	2026-02-04
Q3 2025	$33.61	2025-10-28
Q2 2025	$20.02	2025-08-01
Q1 2026	$7.27	2026-04-29
FY 2025	$38.34	2026-02-04

Full earnings history →

Pharmaceutical Preparations peers

REGN vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

14.08 / 16.82 med

-16% discount

P/S vs peers

4.42 / 3.54 med

+25% premium

Net margin vs peers

31.4% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.